Skip to main content
Year archive

BioSenic SA — 2022 filings

All 91 regulatory filings released by BioSenic SA (BIOS) in 2022, sourced directly from the official regulator.

91 Filings
2022 Period
2022 filings (91)
Filing Released Lang
BIOS_PR_2022-12-01_Denominator_EN_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-12-01 English
BIOS_PR_2022-12-01_Denominator_FR_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-12-01 French
BIOS_PR_2022-11-21_Transparency Notification_Multiple_EN_vfinal.pdf
Major Shareholding Notification
2022-11-21 English
BIOS_PR_2022-11-21_Transparency Notification_Multiple_FR_vfinal.pdf
Director's Dealing
2022-11-21 French
BIOS_PR_2022_11_04_Transparency_Notification_S.R.I.W_EN_web.pdf
Major Shareholding Notification
2022-11-04 English
BIOS_PR_2022_11_04_Transparency_Notification_S.R.I.W_FR_v01.pdf
Director's Dealing
2022-11-04 French
BOTHE_PR_2022-11-03_Denominator_EN_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-11-03 English
BOTHE_PR_2022-11-03_Denominator_FR_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-11-03 French
BOTHE_PR_2022-10-25_EGM Result_EN_vfinal.pdf
Board/Management Information
2022-10-25 English
BOTHE_PR_2022-10-25_EGM Result_FR_vfinal.pdf
AGM Information
2022-10-25 French
BOTHE_PR_2022-10-21_2022-Q3_EN_vfinal.pdf
Earnings Release Q3 2022
2022-10-21 English
BOTHE_PR_2022-10-21_2022-Q3_FR_vfinal.pdf
Earnings Release Q3 2022
2022-10-21 French
Transparancy_FPIM - Transparancy Notice Bone Therapeutics 0882-015-654 Part I .pdf
Major Shareholding Notification
2022-10-11 Dutch
BOTHE_PR_2022-10-11_Transparency Notification_S.F.P.I_EN_Final.pdf
Director's Dealing
2022-10-11 English
BOTHE_PR_2022-10-11_Transparency Notification_S.F.P.I_FR_Final.pdf
Major Shareholding Notification
2022-10-11 French
BOTHE_PR_2022-10-07_Pregene_Termination notice_EN_FINAL.pdf
Legal Proceedings Report
2022-10-07 English
BOTHE_PR_2022-10-07_Pregene_Termination notice_FR_FINAL.pdf
Regulatory Filings
2022-10-07 French
BOTHE_PR_2022-10-06_EGM2_EN_vfinal.pdf
AGM Information
2022-10-06 English
BOTHE_PR_2022-10-06_EGM2_FR_vfinal.pdf
AGM Information
2022-10-06 French
BOTHE_PR_2022-09-30_Denominator_EN_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-09-30 English
BOTHE_PR_2022-09-30_Denominator_FR_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-09-30 French
BOTHE_PR_2022-09-07_2022-H1_EN_vfinal.pdf
Interim / Quarterly Report H1 2022
2022-09-07 English
BOTHE_PR_2022-09-07_2022-H1_FR_vfinal.pdf
Interim / Quarterly Report H1 2022
2022-09-07 French
20220630_Bone Therapeutics_Interim Financial Report H1 2022_EN_final.pdf
Interim / Quarterly Report H1 2022
2022-09-07 English
20220630_Bone Therapeutics_Interim Financial Report H1 2022_FR_final.pdf
Interim / Quarterly Report H1 2022
2022-09-07 French
BOTHE_PR_2022-08-31_Denominator_EN_vfinal.pdf
Share Issue/Capital Change
2022-08-31 English
BOTHE_PR_2022-08-31_Denominator_FR_vfinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-08-31 French
BOTHE_PR_2022-09-05_EGM1_EN_vfinal.pdf
AGM Information
2022-08-26 English
BOTHE_PR_2022-09-05_EGM1_FR_vfinal.pdf
AGM Information
2022-08-26 French
BOTHE_PR_2022-08-10_Contribution agreement Medsenic_EN_Final.pdf
M&A Activity
2022-08-26 English
BOTHE_PR_2022-08-10_Contribution agreement Medsenic_FR_Final.pdf
M&A Activity
2022-08-26 French
BOTHE_PR_2022-08-10_Contribution agreement Medsenic_EN_Final.pdf
M&A Activity
2022-08-10 English
BOTHE_PR_2022-08-10_Contribution agreement Medsenic_FR_Final.pdf
M&A Activity
2022-08-10 French
BOTHE_PR_2022-07-29_Denominator_EN_vFinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-07-29 English
BOTHE_PR_2022-07-29_Denominator_FR_vFinal.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-07-29 French
BOTHE_PR_2022-07-15_ALLOB-TF2_Amendment_EN_vFinal.pdf
Regulatory Filings
2022-07-15 English
BOTHE_PR_2022-07-15_ALLOB-TF2_Amendment_FR_vFinal.pdf
Regulatory Filings
2022-07-15 French
BOTHE_PR_2022-06-30_Denominator_EN_vFinal.pdf
Share Issue/Capital Change
2022-06-30 English
BOTHE_PR_2022-06-30_Denominator_FR_vFinal.pdf
Share Issue/Capital Change
2022-06-30 French
BOTHE_2022-06-22_Acte-Notaire_AGE.pdf
AGM Information
2022-06-16 French
03_BOTHE_EGM_20220713_Information shareholders rights_EN_vFinal.pdf
AGM Information
2022-06-13 English
01_BOTHE_EGM-20220713_Convocation_FR_vFinal.pdf
AGM Information
2022-06-13 French
01_BOTHE_EGM-20220713_Convening notice_EN_vFinal.pdf
AGM Information
2022-06-13 English
02_BOTHE_EGM-20220713_Procuration_FR_vFinal.pdf
Proxy Solicitation & Information Statement
2022-06-13 French
02_BOTHE_EGM-20220713_Proxy_EN_vFinal.pdf
Proxy Solicitation & Information Statement
2022-06-13 English
03_BOTHE_EGM_20220713_Information droits actionnaires_FR_vFinal.pdf
AGM Information
2022-06-13 French
BOTHE_PR_2022-06-13_EGM2_EN_vFinal.pdf
AGM Information
2022-06-13 English
BOTHE_PR_2022-06-13_EGM2_FR_vFinal.pdf
Report Publication Announcement
2022-06-13 French
BOTHE_20220608_AGO_PV_signed.pdf
AGM Information
2022-06-10 French
BOTHE_PR_2022-06-01_2022-Q1_EN_vFinal.pdf
Earnings Release Q1 2022
2022-06-01 English
BOTHE_PR_2022-06-01_2022-Q1_FR_vFinal.pdf
Earnings Release Q1 2022
2022-06-01 French
Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO
Capital/Financing Update
2022-05-31 English
Bone Therapeutics signe un accord définitif de souscription pour l’émission d’obligations convertibles d’un maximum de 5 M€ avec ABO
Capital/Financing Update
2022-05-31 French
BOTHE_Rapport-spécial_Art7198-juncto7180-7191-7193_Executed_version 20220531.pdf
Share Issue/Capital Change
2022-05-31 French
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
M&A Activity
2022-05-12 English
Bone Therapeutics entre en discussions exclusives dans le cadre d’un projet de fusion inversée avec Medsenic
M&A Activity
2022-05-12 French
07_BOTHE_Statutory-PIE-opinion_Deloitte_FR.pdf
Audit Report / Information FY 2021
2022-05-09 French
06_BOTHE_Rapport de gestion_2021.pdf
Management Reports FY 2021
2022-05-09 French
04_BOTHE_AR2021_EN_vFinal.pdf
Annual Report FY 2021
2022-05-09 English
04_BOTHE_AR2021_FR_vFinal.pdf
Annual Report FY 2021
2022-05-09 French
03_BOTHE_EGM_20220608_Information shareholders rights_EN_vFinal.pdf
AGM Information
2022-05-09 English
01_BOTHE_EGM-20220608_Convening notice_FR_vFinal.pdf
AGM Information
2022-05-09 French
02_BOTHE_EGM-20220608_Proxy form_EN_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 English
03_BOTHE_EGM_20220608_Information droits actionnaires_FR_vFinal.pdf
AGM Information
2022-05-09 French
01_BOTHE_EGM-20220608_Convening notice_EN_vFinal.pdf
AGM Information
2022-05-09 English
02_BOTHE_EGM-20220608_Procuration_FR_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 French
01_BOTHE_Convening notice AGM 20220608_EN_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 English
07_BOTHE_Statutory-PIE-opinion_Deloitte_EN.pdf
Audit Report / Information FY 2021
2022-05-09 English
02_BOTHE_AGM-2022_Proxy form_EN_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 English
02_BOTHE_AGM-2022_Procuration_FR_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 French
05_BOTHE_Comptes annuels_2021.pdf
Annual Report FY 2021
2022-05-09 French
01_BOTHE_Convening notice AGM 20220608_FR_vFinal.pdf
Proxy Solicitation & Information Statement
2022-05-09 French
BOTHE_PR_2022-05-09_AGM-EGM 2022_EN_vFinal.pdf
AGM Information
2022-05-09 English
BOTHE_PR_2022-05-09_AGM-EGM 2022_FR_vFinal.pdf
AGM Information
2022-05-09 French
BOTHE_AR2021_EN_vFinal.pdf
Annual Report FY 2021
2022-04-29 English
BOTHE_AR2021_FR_vFinal.pdf
Annual Report FY 2021
2022-04-29 French
549300HFIIMTOP1DFR76-2021-12-31-en.xhtml
Annual Report FY 2021
2022-04-29 English
BOTHE_AR2021_EN_549300HFIIMTOP1DFR76.zip
Annual Report (ESEF) FY 2021
2022-04-29 English
549300HFIIMTOP1DFR76-2021-12-31-fr.xhtml
Annual Report FY 2021
2022-04-29 French
BOTHE_AR2021_FR_549300HFIIMTOP1DFR76.zip
Annual Report (ESEF) FY 2021
2022-04-29 French
BOTHE_PR_2022-04-29_FY 2021_EN_Final_Long.pdf
Earnings Release FY 2021
2022-04-29 English
BOTHE_PR_2022-04-29_FY 2021_FR_Final_Long.pdf
Earnings Release FY 2021
2022-04-29 French
Bone Therapeutics Secures EUR 5 Million Financing
Capital/Financing Update
2022-04-12 English
Bone Therapeutics obtient un financement de 5 M€
Capital/Financing Update
2022-04-12 French
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
Board/Management Information
2022-03-29 English
Bone Therapeutics réoriente sa stratégie autour du développement d’ALLOB, son produit de thérapie cellulaire phare
Regulatory Filings
2022-03-29 French
20220316 Melding FSMA_Nyenburgh Holding BV_signed_v2.pdf
Major Shareholding Notification
2022-03-23 Dutch
BOTHE_PR_2022-03-23_Transparency Notification_Nyenburgh_EN_Final.pdf
Director's Dealing
2022-03-23 English
BOTHE_PR_2022-03-23_Transparency Notification_Nyenburgh_FR_Final.pdf
Major Shareholding Notification
2022-03-23 French
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
Earnings Release Q4 2021
2022-01-19 English
Bone Therapeutics fait le point sur ses activités au quatrième trimestre 2021 et sur ses perspectives de développement en 2022
Earnings Release Q4 2021
2022-01-19 French